Karen L Tubridy's Net Worth
$410 Thousand
Who is Karen L Tubridy?
Karen L Tubridy does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Eleven Biotherapeutics, Inc., and Akebia Therapeutics, Inc..
SEC CIK
Karen L Tubridy's CIK is 0001589888
Past Insider Trading and Trends
2016 was Karen L Tubridy's most active year for acquiring shares with 5 total transactions. Karen L Tubridy's most active month to acquire stocks was the month of January. 2015 was Karen L Tubridy's most active year for disposing of shares, totalling 1 transactions. Karen L Tubridy's most active month to dispose stocks was the month of November. 2017 saw Karen L Tubridy paying a total of $370,110.00 for 59,500 shares, this is the most they've acquired in one year. In 2018 Karen L Tubridy cashed out on 11,928 shares for a total of $106,636.32, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Eleven Biotherapeutics, Inc. (CARM) Snapshot price: $2
Chief Development Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 9
| |||
Form 4
| -11.78% | -4.37K |
$2.08 | -$9,093.76 | 32.75K |
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
| -11.84% | -4.43K |
$2.85 | -$12,616.95 | 32.97K |
Dec 28
| |||
Form 4
|
∞
| 37.4K |
—
|
—
| 37.4K |
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akebia Therapeutics, Inc. (AKBA) Snapshot price: $1.65
SVP, Chief Development Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +45.66% | 26.55K |
$8.70 | -$30,049.80 | 84.68K |
Feb 28
| |||
Form 4
| -9.89% | -6.08K |
$7.70 | -$46,777.50 | 55.32K |
Apr 11
| |||
Form 4
| +95.54% | 30K |
—
|
—
| 61.4K |
Feb 28
| |||
Form 4
| -28.29% | -11.93K |
$8.94 | -$106,636.32 | 30.23K |
Dec 12
| |||
Form 4
| +72.86% | 17.5K |
—
|
—
| 41.52K |
Feb 28
| |||
Form 4
|
∞
| 23K |
—
|
—
| 23K |
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||